Global Varicella Attenuated Live Vaccination Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
LPI (LP Information)' newest research report, the “Varicella Attenuated Live Vaccination Industry Forecast” looks at past sales and reviews total world Varicella Attenuated Live Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Varicella Attenuated Live Vaccination sales for 2023 through 2029. With Varicella Attenuated Live Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Varicella Attenuated Live Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Varicella Attenuated Live Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Varicella Attenuated Live Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Varicella Attenuated Live Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Varicella Attenuated Live Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Varicella Attenuated Live Vaccination.
The global Varicella Attenuated Live Vaccination market size is projected to grow from US$ 2498.1 million in 2022 to US$ 3074 million in 2029; it is expected to grow at a CAGR of 3074 from 2023 to 2029.
For the major players of Varicella Attenuated Live Vaccine, Merck maintained its first place in the ranking in 2019, followed by BCHT, Shanghai Institute, GSK and Keygen. Top 5 players accounted for about 95% of the Global Varicella Attenuated Live Vaccine revenue market share in 2019.
The sales market for Varicella Attenuated Live Vaccine was divided into five geographic regions. Asia-Pacific occupied the largest sales market share with about 58% in 2019. It is followed by North America and Europe with about 18% and about 13% respectively, while other regions have smaller market.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Attenuated Live Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Varicella Attenuated Live Vaccination market?
What factors are driving Varicella Attenuated Live Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Varicella Attenuated Live Vaccination market opportunities vary by end market size?
How does Varicella Attenuated Live Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
LPI (LP Information)' newest research report, the “Varicella Attenuated Live Vaccination Industry Forecast” looks at past sales and reviews total world Varicella Attenuated Live Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Varicella Attenuated Live Vaccination sales for 2023 through 2029. With Varicella Attenuated Live Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Varicella Attenuated Live Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Varicella Attenuated Live Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Varicella Attenuated Live Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Varicella Attenuated Live Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Varicella Attenuated Live Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Varicella Attenuated Live Vaccination.
The global Varicella Attenuated Live Vaccination market size is projected to grow from US$ 2498.1 million in 2022 to US$ 3074 million in 2029; it is expected to grow at a CAGR of 3074 from 2023 to 2029.
For the major players of Varicella Attenuated Live Vaccine, Merck maintained its first place in the ranking in 2019, followed by BCHT, Shanghai Institute, GSK and Keygen. Top 5 players accounted for about 95% of the Global Varicella Attenuated Live Vaccine revenue market share in 2019.
The sales market for Varicella Attenuated Live Vaccine was divided into five geographic regions. Asia-Pacific occupied the largest sales market share with about 58% in 2019. It is followed by North America and Europe with about 18% and about 13% respectively, while other regions have smaller market.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Attenuated Live Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Monovalent Vaccine
- Combination Vaccine
- Children
- Adults
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- BCHT
- Shanghai Institute
- GSK
- Keygen
- Green Cross
- Biken
- Shanghai Rongsheng Biotech
- Changsheng
What is the 10-year outlook for the global Varicella Attenuated Live Vaccination market?
What factors are driving Varicella Attenuated Live Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Varicella Attenuated Live Vaccination market opportunities vary by end market size?
How does Varicella Attenuated Live Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Varicella Attenuated Live Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Varicella Attenuated Live Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Varicella Attenuated Live Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Varicella Attenuated Live Vaccination Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Combination Vaccine
2.3 Varicella Attenuated Live Vaccination Sales by Type
2.3.1 Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Varicella Attenuated Live Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Varicella Attenuated Live Vaccination Sale Price by Type (2018-2023)
2.4 Varicella Attenuated Live Vaccination Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Varicella Attenuated Live Vaccination Sales by Application
2.5.1 Global Varicella Attenuated Live Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Varicella Attenuated Live Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Varicella Attenuated Live Vaccination Sale Price by Application (2018-2023)
3 GLOBAL VARICELLA ATTENUATED LIVE VACCINATION BY COMPANY
3.1 Global Varicella Attenuated Live Vaccination Breakdown Data by Company
3.1.1 Global Varicella Attenuated Live Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Varicella Attenuated Live Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Varicella Attenuated Live Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Varicella Attenuated Live Vaccination Revenue by Company (2018-2023)
3.2.2 Global Varicella Attenuated Live Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Varicella Attenuated Live Vaccination Sale Price by Company
3.4 Key Manufacturers Varicella Attenuated Live Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Attenuated Live Vaccination Product Location Distribution
3.4.2 Players Varicella Attenuated Live Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VARICELLA ATTENUATED LIVE VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Varicella Attenuated Live Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Varicella Attenuated Live Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Varicella Attenuated Live Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Varicella Attenuated Live Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Varicella Attenuated Live Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Varicella Attenuated Live Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Varicella Attenuated Live Vaccination Sales Growth
4.4 APAC Varicella Attenuated Live Vaccination Sales Growth
4.5 Europe Varicella Attenuated Live Vaccination Sales Growth
4.6 Middle East & Africa Varicella Attenuated Live Vaccination Sales Growth
5 AMERICAS
5.1 Americas Varicella Attenuated Live Vaccination Sales by Country
5.1.1 Americas Varicella Attenuated Live Vaccination Sales by Country (2018-2023)
5.1.2 Americas Varicella Attenuated Live Vaccination Revenue by Country (2018-2023)
5.2 Americas Varicella Attenuated Live Vaccination Sales by Type
5.3 Americas Varicella Attenuated Live Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Varicella Attenuated Live Vaccination Sales by Region
6.1.1 APAC Varicella Attenuated Live Vaccination Sales by Region (2018-2023)
6.1.2 APAC Varicella Attenuated Live Vaccination Revenue by Region (2018-2023)
6.2 APAC Varicella Attenuated Live Vaccination Sales by Type
6.3 APAC Varicella Attenuated Live Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Varicella Attenuated Live Vaccination by Country
7.1.1 Europe Varicella Attenuated Live Vaccination Sales by Country (2018-2023)
7.1.2 Europe Varicella Attenuated Live Vaccination Revenue by Country (2018-2023)
7.2 Europe Varicella Attenuated Live Vaccination Sales by Type
7.3 Europe Varicella Attenuated Live Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Varicella Attenuated Live Vaccination by Country
8.1.1 Middle East & Africa Varicella Attenuated Live Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Varicella Attenuated Live Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Varicella Attenuated Live Vaccination Sales by Type
8.3 Middle East & Africa Varicella Attenuated Live Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccination
10.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccination
10.4 Industry Chain Structure of Varicella Attenuated Live Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Varicella Attenuated Live Vaccination Distributors
11.3 Varicella Attenuated Live Vaccination Customer
12 WORLD FORECAST REVIEW FOR VARICELLA ATTENUATED LIVE VACCINATION BY GEOGRAPHIC REGION
12.1 Global Varicella Attenuated Live Vaccination Market Size Forecast by Region
12.1.1 Global Varicella Attenuated Live Vaccination Forecast by Region (2024-2029)
12.1.2 Global Varicella Attenuated Live Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Varicella Attenuated Live Vaccination Forecast by Type
12.7 Global Varicella Attenuated Live Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.1.3 Merck Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 BCHT
13.2.1 BCHT Company Information
13.2.2 BCHT Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.2.3 BCHT Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BCHT Main Business Overview
13.2.5 BCHT Latest Developments
13.3 Shanghai Institute
13.3.1 Shanghai Institute Company Information
13.3.2 Shanghai Institute Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.3.3 Shanghai Institute Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shanghai Institute Main Business Overview
13.3.5 Shanghai Institute Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.4.3 GSK Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Keygen
13.5.1 Keygen Company Information
13.5.2 Keygen Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.5.3 Keygen Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Keygen Main Business Overview
13.5.5 Keygen Latest Developments
13.6 Green Cross
13.6.1 Green Cross Company Information
13.6.2 Green Cross Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.6.3 Green Cross Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Green Cross Main Business Overview
13.6.5 Green Cross Latest Developments
13.7 Biken
13.7.1 Biken Company Information
13.7.2 Biken Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.7.3 Biken Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biken Main Business Overview
13.7.5 Biken Latest Developments
13.8 Shanghai Rongsheng Biotech
13.8.1 Shanghai Rongsheng Biotech Company Information
13.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shanghai Rongsheng Biotech Main Business Overview
13.8.5 Shanghai Rongsheng Biotech Latest Developments
13.9 Changsheng
13.9.1 Changsheng Company Information
13.9.2 Changsheng Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.9.3 Changsheng Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changsheng Main Business Overview
13.9.5 Changsheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Varicella Attenuated Live Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Varicella Attenuated Live Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Varicella Attenuated Live Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Varicella Attenuated Live Vaccination Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Combination Vaccine
2.3 Varicella Attenuated Live Vaccination Sales by Type
2.3.1 Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Varicella Attenuated Live Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Varicella Attenuated Live Vaccination Sale Price by Type (2018-2023)
2.4 Varicella Attenuated Live Vaccination Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Varicella Attenuated Live Vaccination Sales by Application
2.5.1 Global Varicella Attenuated Live Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Varicella Attenuated Live Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Varicella Attenuated Live Vaccination Sale Price by Application (2018-2023)
3 GLOBAL VARICELLA ATTENUATED LIVE VACCINATION BY COMPANY
3.1 Global Varicella Attenuated Live Vaccination Breakdown Data by Company
3.1.1 Global Varicella Attenuated Live Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Varicella Attenuated Live Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Varicella Attenuated Live Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Varicella Attenuated Live Vaccination Revenue by Company (2018-2023)
3.2.2 Global Varicella Attenuated Live Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Varicella Attenuated Live Vaccination Sale Price by Company
3.4 Key Manufacturers Varicella Attenuated Live Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Attenuated Live Vaccination Product Location Distribution
3.4.2 Players Varicella Attenuated Live Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VARICELLA ATTENUATED LIVE VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Varicella Attenuated Live Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Varicella Attenuated Live Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Varicella Attenuated Live Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Varicella Attenuated Live Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Varicella Attenuated Live Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Varicella Attenuated Live Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Varicella Attenuated Live Vaccination Sales Growth
4.4 APAC Varicella Attenuated Live Vaccination Sales Growth
4.5 Europe Varicella Attenuated Live Vaccination Sales Growth
4.6 Middle East & Africa Varicella Attenuated Live Vaccination Sales Growth
5 AMERICAS
5.1 Americas Varicella Attenuated Live Vaccination Sales by Country
5.1.1 Americas Varicella Attenuated Live Vaccination Sales by Country (2018-2023)
5.1.2 Americas Varicella Attenuated Live Vaccination Revenue by Country (2018-2023)
5.2 Americas Varicella Attenuated Live Vaccination Sales by Type
5.3 Americas Varicella Attenuated Live Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Varicella Attenuated Live Vaccination Sales by Region
6.1.1 APAC Varicella Attenuated Live Vaccination Sales by Region (2018-2023)
6.1.2 APAC Varicella Attenuated Live Vaccination Revenue by Region (2018-2023)
6.2 APAC Varicella Attenuated Live Vaccination Sales by Type
6.3 APAC Varicella Attenuated Live Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Varicella Attenuated Live Vaccination by Country
7.1.1 Europe Varicella Attenuated Live Vaccination Sales by Country (2018-2023)
7.1.2 Europe Varicella Attenuated Live Vaccination Revenue by Country (2018-2023)
7.2 Europe Varicella Attenuated Live Vaccination Sales by Type
7.3 Europe Varicella Attenuated Live Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Varicella Attenuated Live Vaccination by Country
8.1.1 Middle East & Africa Varicella Attenuated Live Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Varicella Attenuated Live Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Varicella Attenuated Live Vaccination Sales by Type
8.3 Middle East & Africa Varicella Attenuated Live Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccination
10.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccination
10.4 Industry Chain Structure of Varicella Attenuated Live Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Varicella Attenuated Live Vaccination Distributors
11.3 Varicella Attenuated Live Vaccination Customer
12 WORLD FORECAST REVIEW FOR VARICELLA ATTENUATED LIVE VACCINATION BY GEOGRAPHIC REGION
12.1 Global Varicella Attenuated Live Vaccination Market Size Forecast by Region
12.1.1 Global Varicella Attenuated Live Vaccination Forecast by Region (2024-2029)
12.1.2 Global Varicella Attenuated Live Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Varicella Attenuated Live Vaccination Forecast by Type
12.7 Global Varicella Attenuated Live Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.1.3 Merck Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 BCHT
13.2.1 BCHT Company Information
13.2.2 BCHT Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.2.3 BCHT Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BCHT Main Business Overview
13.2.5 BCHT Latest Developments
13.3 Shanghai Institute
13.3.1 Shanghai Institute Company Information
13.3.2 Shanghai Institute Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.3.3 Shanghai Institute Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shanghai Institute Main Business Overview
13.3.5 Shanghai Institute Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.4.3 GSK Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Keygen
13.5.1 Keygen Company Information
13.5.2 Keygen Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.5.3 Keygen Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Keygen Main Business Overview
13.5.5 Keygen Latest Developments
13.6 Green Cross
13.6.1 Green Cross Company Information
13.6.2 Green Cross Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.6.3 Green Cross Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Green Cross Main Business Overview
13.6.5 Green Cross Latest Developments
13.7 Biken
13.7.1 Biken Company Information
13.7.2 Biken Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.7.3 Biken Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biken Main Business Overview
13.7.5 Biken Latest Developments
13.8 Shanghai Rongsheng Biotech
13.8.1 Shanghai Rongsheng Biotech Company Information
13.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shanghai Rongsheng Biotech Main Business Overview
13.8.5 Shanghai Rongsheng Biotech Latest Developments
13.9 Changsheng
13.9.1 Changsheng Company Information
13.9.2 Changsheng Varicella Attenuated Live Vaccination Product Portfolios and Specifications
13.9.3 Changsheng Varicella Attenuated Live Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changsheng Main Business Overview
13.9.5 Changsheng Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Varicella Attenuated Live Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Varicella Attenuated Live Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Combination Vaccine
Table 5. Global Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 6. Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Table 7. Global Varicella Attenuated Live Vaccination Revenue by Type (2018-2023) & ($ million)
Table 8. Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2018-2023)
Table 9. Global Varicella Attenuated Live Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 11. Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Table 12. Global Varicella Attenuated Live Vaccination Revenue by Application (2018-2023)
Table 13. Global Varicella Attenuated Live Vaccination Revenue Market Share by Application (2018-2023)
Table 14. Global Varicella Attenuated Live Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Varicella Attenuated Live Vaccination Sales by Company (2018-2023) & (Units)
Table 16. Global Varicella Attenuated Live Vaccination Sales Market Share by Company (2018-2023)
Table 17. Global Varicella Attenuated Live Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Varicella Attenuated Live Vaccination Revenue Market Share by Company (2018-2023)
Table 19. Global Varicella Attenuated Live Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Varicella Attenuated Live Vaccination Producing Area Distribution and Sales Area
Table 21. Players Varicella Attenuated Live Vaccination Products Offered
Table 22. Varicella Attenuated Live Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Varicella Attenuated Live Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Varicella Attenuated Live Vaccination Sales Market Share Geographic Region (2018-2023)
Table 27. Global Varicella Attenuated Live Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Varicella Attenuated Live Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Varicella Attenuated Live Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Varicella Attenuated Live Vaccination Sales Market Share by Country/Region (2018-2023)
Table 31. Global Varicella Attenuated Live Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Varicella Attenuated Live Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Varicella Attenuated Live Vaccination Sales by Country (2018-2023) & (Units)
Table 34. Americas Varicella Attenuated Live Vaccination Sales Market Share by Country (2018-2023)
Table 35. Americas Varicella Attenuated Live Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Varicella Attenuated Live Vaccination Revenue Market Share by Country (2018-2023)
Table 37. Americas Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 38. Americas Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 39. APAC Varicella Attenuated Live Vaccination Sales by Region (2018-2023) & (Units)
Table 40. APAC Varicella Attenuated Live Vaccination Sales Market Share by Region (2018-2023)
Table 41. APAC Varicella Attenuated Live Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Varicella Attenuated Live Vaccination Revenue Market Share by Region (2018-2023)
Table 43. APAC Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 44. APAC Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 45. Europe Varicella Attenuated Live Vaccination Sales by Country (2018-2023) & (Units)
Table 46. Europe Varicella Attenuated Live Vaccination Sales Market Share by Country (2018-2023)
Table 47. Europe Varicella Attenuated Live Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Varicella Attenuated Live Vaccination Revenue Market Share by Country (2018-2023)
Table 49. Europe Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 50. Europe Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Varicella Attenuated Live Vaccination Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Varicella Attenuated Live Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Varicella Attenuated Live Vaccination Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Varicella Attenuated Live Vaccination
Table 58. Key Market Challenges & Risks of Varicella Attenuated Live Vaccination
Table 59. Key Industry Trends of Varicella Attenuated Live Vaccination
Table 60. Varicella Attenuated Live Vaccination Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Varicella Attenuated Live Vaccination Distributors List
Table 63. Varicella Attenuated Live Vaccination Customer List
Table 64. Global Varicella Attenuated Live Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Varicella Attenuated Live Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Varicella Attenuated Live Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Varicella Attenuated Live Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Varicella Attenuated Live Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Varicella Attenuated Live Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Varicella Attenuated Live Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Varicella Attenuated Live Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Varicella Attenuated Live Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Varicella Attenuated Live Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Varicella Attenuated Live Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Varicella Attenuated Live Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Varicella Attenuated Live Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Varicella Attenuated Live Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 80. Merck Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. BCHT Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 84. BCHT Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 85. BCHT Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BCHT Main Business
Table 87. BCHT Latest Developments
Table 88. Shanghai Institute Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 89. Shanghai Institute Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 90. Shanghai Institute Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Shanghai Institute Main Business
Table 92. Shanghai Institute Latest Developments
Table 93. GSK Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 95. GSK Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Keygen Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. Keygen Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 100. Keygen Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Keygen Main Business
Table 102. Keygen Latest Developments
Table 103. Green Cross Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. Green Cross Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 105. Green Cross Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Green Cross Main Business
Table 107. Green Cross Latest Developments
Table 108. Biken Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Biken Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 110. Biken Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Biken Main Business
Table 112. Biken Latest Developments
Table 113. Shanghai Rongsheng Biotech Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 115. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Shanghai Rongsheng Biotech Main Business
Table 117. Shanghai Rongsheng Biotech Latest Developments
Table 118. Changsheng Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 119. Changsheng Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 120. Changsheng Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Changsheng Main Business
Table 122. Changsheng Latest Developments
Table 1. Varicella Attenuated Live Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Varicella Attenuated Live Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Combination Vaccine
Table 5. Global Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 6. Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Table 7. Global Varicella Attenuated Live Vaccination Revenue by Type (2018-2023) & ($ million)
Table 8. Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2018-2023)
Table 9. Global Varicella Attenuated Live Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 11. Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Table 12. Global Varicella Attenuated Live Vaccination Revenue by Application (2018-2023)
Table 13. Global Varicella Attenuated Live Vaccination Revenue Market Share by Application (2018-2023)
Table 14. Global Varicella Attenuated Live Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Varicella Attenuated Live Vaccination Sales by Company (2018-2023) & (Units)
Table 16. Global Varicella Attenuated Live Vaccination Sales Market Share by Company (2018-2023)
Table 17. Global Varicella Attenuated Live Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Varicella Attenuated Live Vaccination Revenue Market Share by Company (2018-2023)
Table 19. Global Varicella Attenuated Live Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Varicella Attenuated Live Vaccination Producing Area Distribution and Sales Area
Table 21. Players Varicella Attenuated Live Vaccination Products Offered
Table 22. Varicella Attenuated Live Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Varicella Attenuated Live Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Varicella Attenuated Live Vaccination Sales Market Share Geographic Region (2018-2023)
Table 27. Global Varicella Attenuated Live Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Varicella Attenuated Live Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Varicella Attenuated Live Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Varicella Attenuated Live Vaccination Sales Market Share by Country/Region (2018-2023)
Table 31. Global Varicella Attenuated Live Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Varicella Attenuated Live Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Varicella Attenuated Live Vaccination Sales by Country (2018-2023) & (Units)
Table 34. Americas Varicella Attenuated Live Vaccination Sales Market Share by Country (2018-2023)
Table 35. Americas Varicella Attenuated Live Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Varicella Attenuated Live Vaccination Revenue Market Share by Country (2018-2023)
Table 37. Americas Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 38. Americas Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 39. APAC Varicella Attenuated Live Vaccination Sales by Region (2018-2023) & (Units)
Table 40. APAC Varicella Attenuated Live Vaccination Sales Market Share by Region (2018-2023)
Table 41. APAC Varicella Attenuated Live Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Varicella Attenuated Live Vaccination Revenue Market Share by Region (2018-2023)
Table 43. APAC Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 44. APAC Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 45. Europe Varicella Attenuated Live Vaccination Sales by Country (2018-2023) & (Units)
Table 46. Europe Varicella Attenuated Live Vaccination Sales Market Share by Country (2018-2023)
Table 47. Europe Varicella Attenuated Live Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Varicella Attenuated Live Vaccination Revenue Market Share by Country (2018-2023)
Table 49. Europe Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 50. Europe Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Varicella Attenuated Live Vaccination Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Varicella Attenuated Live Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Varicella Attenuated Live Vaccination Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Varicella Attenuated Live Vaccination Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Varicella Attenuated Live Vaccination Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Varicella Attenuated Live Vaccination
Table 58. Key Market Challenges & Risks of Varicella Attenuated Live Vaccination
Table 59. Key Industry Trends of Varicella Attenuated Live Vaccination
Table 60. Varicella Attenuated Live Vaccination Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Varicella Attenuated Live Vaccination Distributors List
Table 63. Varicella Attenuated Live Vaccination Customer List
Table 64. Global Varicella Attenuated Live Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Varicella Attenuated Live Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Varicella Attenuated Live Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Varicella Attenuated Live Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Varicella Attenuated Live Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Varicella Attenuated Live Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Varicella Attenuated Live Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Varicella Attenuated Live Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Varicella Attenuated Live Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Varicella Attenuated Live Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Varicella Attenuated Live Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Varicella Attenuated Live Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Varicella Attenuated Live Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Varicella Attenuated Live Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 80. Merck Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. BCHT Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 84. BCHT Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 85. BCHT Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BCHT Main Business
Table 87. BCHT Latest Developments
Table 88. Shanghai Institute Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 89. Shanghai Institute Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 90. Shanghai Institute Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Shanghai Institute Main Business
Table 92. Shanghai Institute Latest Developments
Table 93. GSK Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 95. GSK Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Keygen Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. Keygen Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 100. Keygen Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Keygen Main Business
Table 102. Keygen Latest Developments
Table 103. Green Cross Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. Green Cross Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 105. Green Cross Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Green Cross Main Business
Table 107. Green Cross Latest Developments
Table 108. Biken Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Biken Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 110. Biken Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Biken Main Business
Table 112. Biken Latest Developments
Table 113. Shanghai Rongsheng Biotech Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 115. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Shanghai Rongsheng Biotech Main Business
Table 117. Shanghai Rongsheng Biotech Latest Developments
Table 118. Changsheng Basic Information, Varicella Attenuated Live Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 119. Changsheng Varicella Attenuated Live Vaccination Product Portfolios and Specifications
Table 120. Changsheng Varicella Attenuated Live Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Changsheng Main Business
Table 122. Changsheng Latest Developments
LIST OF FIGURES
Figure 1. Picture of Varicella Attenuated Live Vaccination
Figure 2. Varicella Attenuated Live Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Attenuated Live Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Varicella Attenuated Live Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Varicella Attenuated Live Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Vaccine
Figure 10. Product Picture of Combination Vaccine
Figure 11. Global Varicella Attenuated Live Vaccination Sales Market Share by Type in 2022
Figure 12. Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2018-2023)
Figure 13. Varicella Attenuated Live Vaccination Consumed in Children
Figure 14. Global Varicella Attenuated Live Vaccination Market: Children (2018-2023) & (Units)
Figure 15. Varicella Attenuated Live Vaccination Consumed in Adults
Figure 16. Global Varicella Attenuated Live Vaccination Market: Adults (2018-2023) & (Units)
Figure 17. Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2022)
Figure 18. Global Varicella Attenuated Live Vaccination Revenue Market Share by Application in 2022
Figure 19. Varicella Attenuated Live Vaccination Sales Market by Company in 2022 (Units)
Figure 20. Global Varicella Attenuated Live Vaccination Sales Market Share by Company in 2022
Figure 21. Varicella Attenuated Live Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Varicella Attenuated Live Vaccination Revenue Market Share by Company in 2022
Figure 23. Global Varicella Attenuated Live Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Varicella Attenuated Live Vaccination Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 26. Americas Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 27. APAC Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 28. APAC Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 29. Europe Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 30. Europe Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 33. Americas Varicella Attenuated Live Vaccination Sales Market Share by Country in 2022
Figure 34. Americas Varicella Attenuated Live Vaccination Revenue Market Share by Country in 2022
Figure 35. Americas Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 36. Americas Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 37. United States Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Varicella Attenuated Live Vaccination Sales Market Share by Region in 2022
Figure 42. APAC Varicella Attenuated Live Vaccination Revenue Market Share by Regions in 2022
Figure 43. APAC Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 44. APAC Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 45. China Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Varicella Attenuated Live Vaccination Sales Market Share by Country in 2022
Figure 53. Europe Varicella Attenuated Live Vaccination Revenue Market Share by Country in 2022
Figure 54. Europe Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 55. Europe Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 56. Germany Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Varicella Attenuated Live Vaccination Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 65. Egypt Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccination in 2022
Figure 71. Manufacturing Process Analysis of Varicella Attenuated Live Vaccination
Figure 72. Industry Chain Structure of Varicella Attenuated Live Vaccination
Figure 73. Channels of Distribution
Figure 74. Global Varicella Attenuated Live Vaccination Sales Market Forecast by Region (2024-2029)
Figure 75. Global Varicella Attenuated Live Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Varicella Attenuated Live Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Varicella Attenuated Live Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Varicella Attenuated Live Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Varicella Attenuated Live Vaccination Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Varicella Attenuated Live Vaccination
Figure 2. Varicella Attenuated Live Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Attenuated Live Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Varicella Attenuated Live Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Varicella Attenuated Live Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Vaccine
Figure 10. Product Picture of Combination Vaccine
Figure 11. Global Varicella Attenuated Live Vaccination Sales Market Share by Type in 2022
Figure 12. Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2018-2023)
Figure 13. Varicella Attenuated Live Vaccination Consumed in Children
Figure 14. Global Varicella Attenuated Live Vaccination Market: Children (2018-2023) & (Units)
Figure 15. Varicella Attenuated Live Vaccination Consumed in Adults
Figure 16. Global Varicella Attenuated Live Vaccination Market: Adults (2018-2023) & (Units)
Figure 17. Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2022)
Figure 18. Global Varicella Attenuated Live Vaccination Revenue Market Share by Application in 2022
Figure 19. Varicella Attenuated Live Vaccination Sales Market by Company in 2022 (Units)
Figure 20. Global Varicella Attenuated Live Vaccination Sales Market Share by Company in 2022
Figure 21. Varicella Attenuated Live Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Varicella Attenuated Live Vaccination Revenue Market Share by Company in 2022
Figure 23. Global Varicella Attenuated Live Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Varicella Attenuated Live Vaccination Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 26. Americas Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 27. APAC Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 28. APAC Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 29. Europe Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 30. Europe Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Varicella Attenuated Live Vaccination Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Varicella Attenuated Live Vaccination Revenue 2018-2023 ($ Millions)
Figure 33. Americas Varicella Attenuated Live Vaccination Sales Market Share by Country in 2022
Figure 34. Americas Varicella Attenuated Live Vaccination Revenue Market Share by Country in 2022
Figure 35. Americas Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 36. Americas Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 37. United States Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Varicella Attenuated Live Vaccination Sales Market Share by Region in 2022
Figure 42. APAC Varicella Attenuated Live Vaccination Revenue Market Share by Regions in 2022
Figure 43. APAC Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 44. APAC Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 45. China Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Varicella Attenuated Live Vaccination Sales Market Share by Country in 2022
Figure 53. Europe Varicella Attenuated Live Vaccination Revenue Market Share by Country in 2022
Figure 54. Europe Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 55. Europe Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 56. Germany Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Varicella Attenuated Live Vaccination Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Varicella Attenuated Live Vaccination Sales Market Share by Application (2018-2023)
Figure 65. Egypt Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Varicella Attenuated Live Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Varicella Attenuated Live Vaccination in 2022
Figure 71. Manufacturing Process Analysis of Varicella Attenuated Live Vaccination
Figure 72. Industry Chain Structure of Varicella Attenuated Live Vaccination
Figure 73. Channels of Distribution
Figure 74. Global Varicella Attenuated Live Vaccination Sales Market Forecast by Region (2024-2029)
Figure 75. Global Varicella Attenuated Live Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Varicella Attenuated Live Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Varicella Attenuated Live Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Varicella Attenuated Live Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Varicella Attenuated Live Vaccination Revenue Market Share Forecast by Application (2024-2029)
